Pediatric Cannabinoid Hyperemesis Two Cases

被引：21

作者：

Miller, Joseph B. ^{[1
]}

Walsh, Mark ^{[2
]}

Patel, Pankaj A. ^{[3
]}

Rogan, Michael ^{[2
]}

Arnold, Cliff ^{[2
]}

Maloney, Megan ^{[2
]}

Donnino, Michael ^{[4
,5
]}

机构：

[1] Henry Ford Hosp, Dept Emergency Med, Detroit, MI 48202 USA

[2] Mem Hosp, Dept Emergency Med, South Bend, IN USA

[3] Mem Hosp, Dept Gastroenterol, South Bend, IN USA

[4] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA

[5] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care, Boston, MA 02215 USA

来源：

PEDIATRIC EMERGENCY CARE | 2010年 / 26卷 / 12期

关键词：

cannabinoid hyperemesis; cyclical vomiting; marijuana; cannabinoids;

D O I：

10.1097/PEC.0b013e3181fe9189

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Cannabinoid hyperemesis has recently been described in the literature. It is a syndrome characterized by severe nausea and hyperemesis in the setting of chronic marijuana abuse and, to date, has been described only in adults. We describe the syndrome in 2 pediatric patients, for whom extensive gastrointestinal workups failed to identify a clear cause and cessation of marijuana use resulted in the alleviation of their symptoms. As in most published adult cases, compulsive bathing was present in both of these cases.

引用

页码：919 / 920

页数：2

共 14 条

[1] Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse [J].

Allen, JH ;

de Moore, GM ;

Heddle, R ;

Twartz, JC .

GUT, 2004, 53 (11) :1566-1570

[2]

Budhraja V, 2008, PRACT GASTROENTEROL, V32, P79

[3] Cannabinoid Hyperemesis Relieved by Compulsive Bathing [J].

Chang, Yoon Hee ;

Windish, Donna M. .

MAYO CLINIC PROCEEDINGS, 2009, 84 (01) :76-78

[4] Prevalence of marijuana use disorders in the United States - 1991-1992 and 2001-2002 [J].

Compton, WM ;

Grant, BF ;

Colliver, JD ;

Glantz, MD ;

Stinson, FS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (17) :2114-2121

[5] Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva) [J].

Darmani, NA ;

Crim, JL .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 80 (01) :35-44

[6] MEDICAL PROGRESS Renal Failure in Cirrhosis [J].

Gines, Pere ;

Schrier, Robert W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1279-1290

[7] Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects [J].

Izzo, A. A. ;

Camilleri, M. .

GUT, 2008, 57 (08) :1140-1155

[8]

McCallum RW, 1999, ALIMENT PHARM THERAP, V13, P77

[9] Role of cannabinoids in chronic liver diseases [J].

Parfieniuk, Anna ;

Flisiak, Robert .

WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) :6109-6114

[10]

Roche E, 2005, GUT, V54, P731

← 1 2 →